HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

More ED-Spiked Supplements Sold On Amazon Recalled Following US FDA Tests

Executive Summary

US FDA published announcement by two firms recalling products they sold under the brand Thumbs Up 7 and that were found in FDA tests to contain undeclared sildenafil and tadalafil.

You may also be interested in...



Consumer Health Products Claiming Treatments For Moles, COVID-19 Back On US FDA Warning Radar

Product sold on Amazon among topical remedies for mole and skin tag removal back on US regulatory radar. Recent warnings show violative COVID-19 claims haven’t disappeared and supplement GMP problems remain common.

Amazon’s Dietary Supplement Quality Control Standards Well-Intended But Short-Sighted

Amazon’s quality control requirements for supplements shouldn’t rely on third-party certification for finished-product specifications but on FDA’s GMPs, says consultant Tara Couch. Attorneys Robert Durkin and Kevin Bell say companies are gaming the system by submitting fraudulent CoAs.

Wellness Industry Group News: CRN Redesigns OWL, AHPA Comments On FSMA Proposal

CNR’s Online Wellness Library gets a new design for easier navigation; AHPA requests revisions to FDA’s food recordkeeping directive; and NPA touts legislative win in Illinois.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS151169

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel